TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
REPL

Replimune Group Inc

Healthcare · Biotechnology

12.40$ -1.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet REPL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
98.2% 99.3% 91.4% 74.4% 89.1% 87.6% 91.7% 88.9% 89.9% 84.0%
90.2% 27.0% 16.7% 25.4% 33.6% 23.0% 22.7% 15.3% 20.2% 62.9%
90.2% 94.5% 87.4% 72.0% 87.7% 85.8% 90.2% 86.3% 87.8% 80.9%
6.2% 3.7% 1.6% 1.3% 0.5% 0.7% 0.5% 1.0% 0.7% 0.5%
– – – -1.3% -0.5% – – – – –
1.5% 0.6% 7.9% 24.9% 1.4% 12.1% – – – –
150.5% 143.1% 10.7% 21.5% 8.2% 10.8% 14.1% 23.2% 24.6% 50.0%
8.7% 7.9% 6.4% 5.1% 2.7% 4.5% 5.2% 8.3% 11.3% 17.5%
– – – 1.4% 0.6% 0.8% 0.6% 0.8% 0.7% 1.2%
1.4% 3.1% 4.6% 1.5% 0.4% 0.8% 0.8% 0.5% 2.3% 2.0%
– – 4.3% 4.2% – – 4.4% 9.2% 8.4% 25.1%
-50.5% -43.1% 89.3% 78.5% 91.8% 89.2% 85.9% 76.8% 75.4% 50.0%
-40.4% -44.4% -38.7% -48.0% -35.6% -67.5% -75.1% -143.8% -172.1% -379.8%
135.1% 47.3% 15.0% 14.6% 8.5% 11.3% 9.0% 13.6% 14.6% 27.9%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?